[Can the risk of neonatal infection be reduced in prematurely ruptured membranes?].
Debodinance
P
P
Clinique Universitaire de Gynécologie-Obstétrique et Pathologie de la Reproduction, Faculté de Médecine de Lille, Roubaix.
Parmentier
D
D
Devulder
G
G
Closset
P
P
Querleu
D
D
Crépin
G
G
D000653:Amniotic Fluid / Q000737:chemistry / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002821:Chorioamnionitis / Q000150:complications / Q000453:epidemiology / Q000382:microbiology*; D002985:Clinical Protocols / Q000592:standards; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications* / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D017053:Infection Control; D007239:Infections / Q000188:drug therapy / Q000209:etiology; D009504:Neutrophils / Q000737:chemistry; D010808:Physical Examination; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology*; D015995:Prevalence; D011446:Prospective Studies; D014621:Vagina
D000900:Anti-Bacterial Agents
Peut-on réduire le risque infectieux néonatal dans les ruptures prématurées des membranes?